Targeting ubiquitin specific protease 7 in cancer: A deubiquitinase with great prospects

Cell Biochemistry and Function
Farjana Yeasmin KhusbuHan-Chun Chen

Abstract

Deubiquitinase (DUB)-mediated cleavage of ubiquitin chain balances ubiquitination and deubiquitination for determining protein fate. USP7 is one of the best characterized DUBs and functionally important. Numerous proteins have been identified as potential substrates and binding partners of USP7; those play crucial roles in diverse array of cellular and biological processes including tumour suppression, cell cycle, DNA repair, chromatin remodelling, and epigenetic regulation. This review aims at summarizing the current knowledge of this wide association of USP7 with many cellular processes that enlightens the possibility of abnormal USP7 activity in promoting oncogenesis and the importance of identification of specific inhibitors.

References

Jun 13, 2002·Proceedings of the National Academy of Sciences of the United States of America·Ryan Hagglund, Bernard Roizman
Jul 3, 2002·Molecular and Cellular Neurosciences·Sunghoi HongSeongman Kang
Sep 25, 2003·The Journal of Biological Chemistry·Melissa N HolowatyLori Frappier
Apr 3, 2004·Nature·Jordan M CumminsBert Vogelstein
Sep 24, 2004·Nature·Hengbin WangYi Zhang
Dec 6, 2005·Cell·Sebastian M B NijmanRené Bernards
Feb 14, 2006·Nature Structural & Molecular Biology·Yi ShengLori Frappier
May 17, 2006·Genes & Development·Steven BerginkNico P Dantuma
Sep 12, 2006·Nature Cell Biology·Armando van der HorstBoudewijn M T Burgering
Jan 16, 2007·Cell·Lloyd C TrotmanPier Paolo Pandolfi
Apr 20, 2007·Biochemical and Biophysical Research Communications·Young Mi OhJae Hong Seol
Oct 12, 2007·Journal of Proteome Research·Benedikt M KesslerMadelon M Maurice
May 30, 2008·Molecular Biology of the Cell·Roberto PapaitIan Marc Bonapace
Oct 28, 2008·Blood·Sandrine DaubeufKhaled Tolba
Jan 7, 2009·The Journal of Cell Biology·Helene FaustrupNiels Mailand
Jun 6, 2009·Annual Review of Biochemistry·Daniel Finley
Aug 13, 2009·Molecular Cancer Therapeutics·Frédéric CollandLaurent Daviet
Aug 24, 2010·Cellular and Molecular Life Sciences : CMLS·Suresh RamakrishnaKwang-Hyun Baek
Aug 31, 2010·Biochemical and Biophysical Research Communications·Prim de BieAaron Ciechanover
Oct 5, 2010·PloS One·Feroz SarkariLori Frappier
Dec 9, 2010·Nucleic Acids Research·Svetlana V KhoronenkovaGrigory L Dianov
Dec 21, 2010·Nature Cell Biology·Mirjam T EppingRené Bernards
Jan 27, 2011·Journal of Cellular Biochemistry·Weihua QinFabio Spada
May 18, 2011·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Felicitas TholArnold Ganser

❮ Previous
Next ❯

Citations

Sep 25, 2018·Current Drug Targets·Lidong Wang, Ruijun Zhang
Nov 16, 2019·Journal of Experimental & Clinical Cancer Research : CR·Yuchong PengXiong Li
Mar 27, 2020·Scientific Reports·Nathan J SchauerSara J Buhrlage
May 8, 2019·Cell Biochemistry and Function·Md Tariqul IslamHanchun Chen
Jul 26, 2019·Apoptosis : an International Journal on Programmed Cell Death·Beibei ShaPei Li
Jan 19, 2021·Annals of Diagnostic Pathology·Ji SunJie Wang
Nov 7, 2020·Drug Discovery Today·Lauraine NininahazweZhe-Sheng Chen
Sep 3, 2021·Bioorganic Chemistry·Chrisanta HarakandiHang Zhang

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cell Signaling & Cancer Epigenetics (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. This feed covers the latest research on signaling and epigenetics in cell growth and cancer.

Cancer Epigenetics Chromatin Complexes (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. This feed focuses on chromatin complexes and their role in cancer epigenetics.

Cancer Epigenetics (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. Here is the latest research on cancer epigenetics.

Cancer Epigenetics and Chromatin (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. This feed focuses on chromatin and its role in cancer epigenetics please follow this feed to learn more.

Cancer Epigenetics

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. Here is the latest research on cancer epigenetics.

Cancer Epigenetics and Senescence (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may be involved in regulating senescence in cancer cells. This feed captures the latest research on cancer epigenetics and senescence.

Cancer Epigenetics & Methyl-CpG (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. Here is the latest research on cancer epigenetics and methyl-CpG binding proteins including ZBTB38.

Cancer Epigenetics & Metabolism (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. This feed focuses on the relationship between cell metabolism, epigenetics and tumor differentiation.

Related Papers

Critical Reviews in Oncology/hematology
Nishant Singh, Anuradha Bharara Singh
International Journal of Cancer. Journal International Du Cancer
Yatendra Kumar SatijaSanjeev Das
© 2022 Meta ULC. All rights reserved